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Abstract
Background: This study investigated the response of piglets receiving a yeast extract without or with a multi-enzyme
mixture compared with an antimicrobial growth promoter (AGP) on performance, immune status and gut structure
after an E. coli lipopolysaccharide (LPS) challenge. Thirty-six pigs were allotted to six treatments including: a
non-challenged control (NCC); LPS-challenged control (CC); CC + AGP; CC + yeast extract; CC + enzymes; and
CC + enzymes + yeast extract. On d 7, pigs were bled and thereafter injected with LPS or sterile saline. Blood
samples were collected at 6, 48, and 96 h post-challenge. After 96 h post-challenge, pigs were euthanized to
obtain duodenal, jejunal and ileal samples.
Results: Overall (d 1 to 11), compared with CC pigs, AGP attenuated the LPS-induced reduction in ADG (P = 0.004),
ADFI (P = 0.03) and gain/feed ratio (P = 0.01). At 6 h post-challenge, AGP pigs had lower plasma urea N (PUN; P = 0.02)
and serum TNF- α concentration (P = 0.07), and higher platelet count (P = 0.04) and serum IL-10 concentration (P = 0.
02) than CC pigs. At 48 h post-challenge, AGP pigs had lower PUN (P = 0.02) than CC pigs, whereas enzymes + yeast
extract interacted non-additively (P = 0.001) to reduce PUN. At 96 h post-challenge, AGP pigs had lower PUN (P = 0.02)
and higher duodenal (P = 0.03), jejunal (P = 0.01) and ileal (P = 0.07) villus height than CC pigs. In addition, enzymes +
yeast extract interacted additively and non-additively to reduce ileal IFN-γ (P < 0.0001) and IL-10 (P = 0.012) expression,
respectively. Generally, no differences (P > 0.10) were observed between AGP and enzymes + yeast extract pigs
on other measured parameters except for the downregulation of ileal IFN-γ (P < 0.0001) and TNF-α (P = 0.003) in
enzymes + yeast extract pigs at 96 h post-challenge.
Conclusions: The LPS challenged piglets receiving enzymes + yeast extract showed beneficial responses in gut
structure and immunity commensurate with those receiving antibiotics, though the latter had better overall
growth performance.
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Background
Following the ban on sub-therapeutic use of antimicro-
bial growth promoters (AGP) in animal feed in the
European Union [1] and the rising pressure for the same
action in USA and Canada [2], the need for potential
antibiotic alternatives that can promote piglet growth
and health has intensified. Yeast extracts contain various
bioactive compounds including nucleotides and cell wall
polysaccharides (specifically β-glucan and α-mannan)
that are considered beneficial to the growth and gut
health of piglets [3], hence yeast extracts have been con-
sidered to be a potential in-feed antibiotic alternative.
Owing to the presence of various bioactive compounds
in yeast extracts, the mechanism by which yeast extracts
impact piglet growth and gut health is multifaceted. The
main advantage of using yeast extracts as a feed additive
is their affordability, a factor which may have less impact
on feed cost when compared with the pure sources of its
constituent bioactive compounds, thereby facilitating
their adoption in the animal feed industry.
Supplementation of yeast extracts rich in nucleotides
in piglet starter diets is deemed prudent in replenishing
the nucleotide pool sourced from sow milk before weaning
[4]. Nucleotides have been suggested to be “conditionally
essential” nutrients during early weaning [5] because
weaned pigs undergo rapid growth of tissue and organ
systems, a process that is heavily dependent on avail-
ability of DNA, RNA, and ATP energy, whose synthesis
depends on availability of nucleotides. The piglet enter-
ocytes and immune cells have a high rate of replication
but this is hampered by their limited capacity for de
novo synthesis of nucleotides [6], the low concentration
of nucleotides in compounded feed [7], and low voluntary
feed intake by the piglet due to the transition from liquid to
solid feed [8]. This may result in gut atrophy and slow
maturation of both the digestive and immune systems,
which determines the ability of the piglet to utilize nutrients
for growth and to combat pathogens [8].
Supplementation of yeast extracts has been shown to
have an immunostimulating effect, which is associated
with β-glucans and α-mannans present in yeast cell wall.
For instance, it has been reported that yeast β-glucans
prevent the elevation in pro-inflammatory cytokines while
enhancing the production of anti-inflammatory cytokines
when piglets immune system was challenged with lipo-
polysaccharide (LPS) [9] or Escherichia coli [10], whereas
supplementing yeast-derived α-mannans in piglet diets
has been associated with improved weight gain and feed
efficiency, and enhanced function of macrophages in the
intestinal lamina propria [11].
It has been suggested that carbohydrases enhance gut
health by hydrolyzing complex non-starch polysaccha-
rides (NSP), thereby not only increasing nutrient avail-
ability but also inducing a prebiotic effect by releasing
fermentable oligosaccharides that are utilized by host
gut microbiota as an energy source [12–14]. There is a
paucity of studies that simultaneously compare the effects
of yeast extracts with AGP or multi-enzyme mixtures sup-
plementation on growth performance and gut health of
weaned piglets in response to an inflammatory challenge.
Since yeast extracts contain nucleotides and cell wall poly-
saccharides that are considered to enhance the maturation
of the digestive and immune systems of piglets [15], it was
hypothesized that given an immune challenge, piglets re-
ceiving supplemental yeast extract will have well-balanced
immune responses that suppress potentially harmful in-
flammation compared to challenged control pigs. Conse-
quently, the suppression of harmful inflammation will
prevent gut atrophy, encourage voluntary feed intake, and
mitigate growth stasis. Moreover, it was hypothesized that
a simultaneous supplementation of yeast extract and en-
zymes will have a synergistic effect of enhancing growth
performance of the immune-challenged piglet. Therefore,
in the current study, the aim was to determine the re-
sponse of piglets receiving 0.1 % yeast extract without or
with enzymes compared with AGP to an immune system
challenge with E. coli lipopolysaccharide (LPS) on growth
performance, immune status, and gut structure during the
immediate post-weaning period.
Methods
All experimental procedures were reviewed and approved
by the University of Manitoba Animal Care Committee,
and pigs were handled in accordance with the guidelines
described by the Canadian Council on Animal Care [16].
Animals and experimental design
Thirty-six [Duroc × (Yorkshire × Landrace)] male and
female piglets weaned at 21d and with an initial average
body weight of 6.89 ± 0.5 kg were used in an 11-d study.
Pigs were individually housed in pens in an environ-
mentally controlled nursery building. Each pen was
equipped with a feeder, a nipple drinker, and plastic-
covered expanded metal floors. The room temperature
was maintained at 29 ± 1 °C throughout the study.
On d 1, pigs were randomly assigned to six treat-
ments based on the initial body weight resulting in six
replications per treatment. Treatments included: (1)
non-challenged control (NCC; pigs fed the basal diet
and injected with sterile saline on d 7); (2) LPS-
challenged control (CC; pigs fed the basal diet and chal-
lenged by injection with E. coli LPS on d 7); (3) CC +AGP
(pigs fed the basal diet supplemented with an antibiotic
growth promoter (AGP) and challenged with E. coli LPS
on d 7); (4) CC + yeast extract (pigs fed the basal diet sup-
plemented with the yeast extract and challenged with E.
coli LPS on d 7); (5) CC + enzymes (pigs fed the basal diet
supplemented with feed enzymes and challenged with E.
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coli LPS on d 7); and (6) CC + enzymes + yeast extract
(pigs fed the basal diet supplemented with enzymes and
yeast extract, and challenged with E. coli LPS on d 7).
The LPS (E. coli serotype 055: B5; Sigma Chemical Inc.,
St Louis, MO, USA) was dissolved in sterile saline and
administered intramuscularly at 60 μg/kg body weight,
whereas an equivalent amount of sterile saline was ad-
ministered to NCC pigs. The LPS dosage of 60 μg/kg
body weight was based on findings of Rakhshandeh and
de Lange [17], which evaluated models of immune sys-
tem stimulation in pigs and reported that an intramus-
cular injection of LPS at 60 μg/kg body weight can
induce a relatively mild immune system stimulation
that can be used to study how nutritional interventions
interact with the immune system of pigs.
The basal diet (Table 1) was formulated to meet or ex-
ceed the National Research Council [18] requirements for
all nutrients. The yeast extract supplement, Maxi-Gen
Plus, was supplied by Canadian Bio-systems Inc. (Calgary,
AB, Canada) and contained cell wall polysaccharides
(21.6 %), CP (32.7 %), carbohydrates (14.3 %) and a mix-
ture of five nucleotides (1.1 %; adenosine monophosphate,
cytosine monophosphate, inosine monophosphate, uri-
dine monophosphate and guanosine monophosphate.
The AGP supplement, Aureomycin (Pfizer Inc., New
York City, NY, USA), supplied 0.10 g chlortetracycline,
0.10 g sulfamethazine and 0.05 g penicillin per kg of
feed. The multi-carbohydrase enzymes supplement,
Superzyme-OM (Canadian Bio-systems Inc., Calgary,
AB, Canada), supplied 2800 U of cellulase, 400 U of
mannanase, 50 U of galactanase, 1000 U of xylanase,
600 U of glucanase, 2500 U of amylase and 200 U of
protease per kg of diet. All the supplements were top-
dressed to the basal diet.
From d 1 to 7 and 9 to 11, pigs had free access to feed
and water but were pair-fed for 48 h (d 7 to 9) after LPS
or sterile saline injection by restricting the feed allow-
ance of all pigs to 4 % of their body weight so as to ex-
clude the possible effects of LPS-induced food intake
reduction on gastrointestinal characteristics of the pigs.
Feed disappearance and body weight were recorded on d
7 and 11 on pen basis.
Blood sampling and rectal temperature measurement
Whole blood samples (10 mL per pig) were collected
via jugular vein puncture into ethylenediaminetetraace-
tic acid tubes on d 7 (before LPS challenge), and after
6, 48 and 96 h post LPS or saline injection and were
placed on ice until they were processed further. In
addition, on d 7 (before LPS challenge) and after 6 h
post LPS or saline injection, rectal temperature of each
pig was measured and 10-mL blood sample from each
pig was collected into a non-heparinized Vacutainer
tube (Becton Dickinson, Rutherford, NJ) and incubated
at room temperature for 1 h before being centrifuged at
3000 × g for 10 min at 4 °C to obtain serum. Serum
samples were stored at −80 °C until required for analysis.
Ileal, duodenal and jejunal tissue sampling
On d 11, that is 96 h post-challenge, all pigs were
euthanized. A 5 cm section of duodenum, ileum and
jejunum was fixed by immersion in 10 % buffer neutral
formalin, whereas 5 g samples of ileum were also col-
lected, stored in RNA later solution (Qiagen, Hilden,
Germany), and thereafter stored at −80 °C until required
for analysis.





















Total P, % 0.65
Available P, % 0.43
SID Lys, % 1.36
SID Met, % 0.43




Total P, % 0.77
aProvided the following per kilogram of complete diet: 9000 IU of vitamin A;
1500 IU of vitamin D3; 18 mg of vitamin E; 1.5 mg of vitamin K; 250 mg of
choline; 30 mg of niacin; 27.5 mg of calcium pantothenate; 9.4 mg of
riboflavin; 2 mg of pyridoxine; 25 μg of cyanocobalamin; 80 μg of biotin;
0.5 mg of folic acid; 18 mg of Cu from copper sulfate, 110 mg of Zn from zinc
oxide, 0.2 mg of I from calcium iodide, 110 mg of Fe from ferrous sulfate,
50 mg of Mn from manganese dioxide, and 0.3 mg of Se from sodium selenite
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Sample preparation and chemical analyses
Dietary samples were processed and analyzed for CP, Ca
and total P. Crude protein (N × 6.25) was determined
according to method 990.03 of AOAC [19] using a
combustion analyzer (model CNS-2000; Leco Corp., St.
Joseph, MI, USA). Dietary total Ca and P were analyzed
following AOAC [19] procedures (method 990.08) using
a Varian inductively coupled plasma mass spectrometer
(Varian Inc., Palo Alto, CA).
Histomorphology measurements
The formalin-fixed duodenum, ileum and jejunum tissues
were processed at the Veterinary Diagnostic Services
Laboratory (Winnipeg, Manitoba, Canada). Villus height
and crypt depth were measured at 10× magnification
using Axiostar Plus microscope (Carl Zeiss, Oberkochen,
Germany) equipped with a camera (Canon Canada Inc.,
Mississauga, Ontario, Canada) and ImageJ software
(National Institutes of Health, Bethesda, MD) in at least
15 well oriented villus and crypt columns. The villus
height/crypt depth ratio was calculated.
Blood cell counts and plasma urea nitrogen (PUN)
measurement
Whole blood samples were sent to the ManitobaVeterinary
Services Laboratory (Winnipeg, MB, Canada) for complete
blood count and PUN analysis. Complete blood count was
measured using an automated analyzer (Orthoclinical
Johnson & Johnson VITROS 250 Chemistry System;
Diamond Diagnostics, Holliston, MA), whereas PUN
was measured using a Technicon Autoanalyzer System
(Technicon Autoanalyzer Systems, Tarrytown, NY).
Both analyses were measured in duplicate.
Serum TNF-α and IL-10
Serum samples were used to measure the concentration
of IL-10 and TNF-α using the quantitative sandwich
enzyme-linked immunosorbent assay technique using por-
cine IL-10 and TNF-α immunoassay kits (R & D Systems,
Inc., Minneapolis, MN) according to the manufacturer’s
instructions. The optical densities were read on a spec-
trophotometer (Soft Max Pro 3.1.1; Molecular Devices,
Abingdon, Oxfordshire, UK). For each cytokine, the ab-
sorbance was measured at 450 nm with the correction
wavelength set at 540 nm. Cytokine concentrations
were calculated from standards using a 4-parameter
logistic curve fit.
Total RNA extraction and reverse transcription
Total RNA of ileal tissue samples was extracted for the
determination of expression profiles of immune response-
related cytokines. Briefly, approximately 100 mg of tissue
sample was placed in a tube containing 0.5 mL beads
and 1 mL TRIZOL reagent (Invitrogen Canada Inc.,
Burlington, Ontario, Canada) and subjected to bead
beating with PowerLyzer (MO BIO Laboratories, Inc.,
Canada) for 2 min at homogenization level of 2500 psi,
and then chilled on ice for 5 min. The above procedure
was repeated once. Total RNA was then extracted,
washed, and eluted following the manufacturer’s in-
structions for the TRIZOL reagent. RNA concentration
and purity was measured using an ND-1000 spectro-
photometer (NanoDrop Technologies, Wilmington, DE,
USA). To remove genomic DNA contamination, total
RNA was treated with DNase I according to the manu-
facturer’s protocol. Two micrograms of total RNA with
an optical density 260/280 ratio between 1.8 and 2.0
was used for cDNA synthesis using a High Capacity
cDNA Reverse transcription Kit (Applied Biosystems,
Foster City, CA, USA) with RNase inhibitor according
to the manufacturer’s instructions.
Real-time PCR
Real-time PCR for cDNA templates was carried out using
a Bio-Rad CFX Real-time system (BioRad, Hercules, CA,
USA). Each reaction mixture was run in duplicate using
optical 96-well reaction plates (BioRad, Hercules, CA,
USA). Each amplification reaction was carried out with
12.5 μL of iTaq SYBR Green Supermix (BioRad, Hercules,
CA, USA) mixed with 1 μL of each primer set of inter-
feron gamma (IFN-γ), tumor necrosis factor-α (TNF-α),
interleukin (IL)–1β, IL-10, IL-6, and beta-actin (Table 2),
1 μL of cDNA and 9.5 μL of nuclease-free water. Negative
controls were created by replacing cDNA with nuclease-
free water. Amplification consisted of initial denaturation
for 5 min, followed by 40 cycles of denaturation at 95 °C
for 15 s, primer annealing at their individual optimal
temperatures (Tables 2 and 3) for 30 s, and an exten-
sion step at 72 °C for 30 s. After the amplification, a
melting curve analysis with a temperature gradient of
0.1 °C per second from 70 to 95 °C was performed to
confirm that only specific products were amplified.
Statistical analysis
All data were analyzed using the Mixed procedure of
SAS (SAS Inst., Inc., Cary, NC). A 2 × 2 factorial ana-
lysis of variance was conducted to compare yeast ex-
tract and enzymes treatments to determine synergistic
effects of yeast extract and enzymes. Preplanned con-
trasts were used to compare CC with NCC to deter-
mine the LPS effect and to compare CC with other
treatments, AGP with the yeast extract and AGP with
enzymes to determine the effect of the supplements
before and after LPS challenge. For all data analyses,
significance was defined as P < 0.05 and 0.05 < P < 0.10
was considered a trend.
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Results
Growth performance
During d 1 to 7 (pre-challenge), all piglets appeared
healthy and no incidence of diarrhea was observed. In
addition, there was no difference in ADG and gain/
feed ratio (G:F) among treatments except that LPS-
challenged AGP pigs tended to have higher ADFI
than LPS-challenged pigs receiving the yeast extract
(P = 0.06; Table 3). Approximately 1 h post-LPS injec-
tion, piglets receiving LPS injection irrespective of the
dietary treatment began to vomit, became somnolent
and developed diarrhea. The piglets recovered from
vomiting, somnolence and diarrhea between 24 and
48 h post-LPS injection. During d 7 to 11 (post-chal-
lenge), compared with CC pigs, NCC pigs had higher
ADG (P = 0.001) and ADFI (P = 0.003) and tended to
have higher G:F (P = 0.07), whereas LPS-challenged
pigs receiving AGP tended to have higher ADG (P =
0.07). Overall (d 1 to 11), pigs receiving enzymes
irrespective of the yeast extract had higher body
weight (P = 0.048) and ADG (P = 0.017) than pigs not
receiving enzymes. Compared to NCC pigs, LPS-
challenge resulted in a 13 % loss in body weight (P =
0.02), 56 % reduction in ADG (P = 0.004), a 37 % re-
duction in ADFI (P = 0.02) and a 26 % reduction in
G:F (P = 0.02) of CC pigs. Compared to CC pigs, supple-
mentation of AGP improved body weight (P = 0.02), ADG
(P = 0.004), ADFI (P = 0.03) and G:F (P = 0.01). In
addition, LPS-challenged pigs receiving AGP had
higher body weight (P = 0.04) and ADG (P = 0.03) than
LPS-challenged pigs receiving the yeast extract and
tended to have higher ADFI than LPS-challenged pigs
receiving the yeast extract (P = 0.06) or enzymes +
yeast extract (P = 0.08). There were no differences
between AGP and enzymes + yeast extract pigs on
ADG and G:F.
Plasma urea N content and blood cells count
No effect of dietary treatment was observed for PUN
pre-challenge (Table 4). After 6 h post-challenge, pigs re-
ceiving yeast extract irrespective of enzymes had lower
PUN (P = 0.03) than pigs not receiving yeast extract, CC
pigs had higher PUN than NCC pigs (P = 0.01) and LPS-
challenged pigs receiving AGP (P = 0.02). After 48 h
post-challenge, pigs receiving yeast extract irrespective
of enzymes had lower PUN (P = 0.01) than pigs not re-
ceiving yeast extract, CC pigs tended to have higher
PUN than NCC pigs (P = 0.08) and LPS-challenged pigs
receiving AGP (P = 0.02). In addition, LPS-challenged
pigs receiving the yeast extract tended to have lower
PUN than those receiving AGP (P = 0.07). Moreover,
an enzymes × yeast extract interaction (P = 0.001) was
observed showing a non-additive effect of enzymes and
the yeast extract in reducing the PUN of pigs. After
96 h post-challenge, CC pigs had higher PUN than
NCC (P = 0.01) and LPS-challenged pigs receiving
AGP (P = 0.02), whereas LPS-challenged pigs receiving
enzymes + yeast extract tended to have higher PUN
than those receiving AGP (P = 0.09). In addition, a ten-
dency towards an enzymes × yeast extract interaction
(P = 0.057) was observed showing a non-additive effect
of enzymes and the yeast extract in reducing the PUN
of pigs.
A tendency towards an enzymes × yeast extract in-
teraction (P = 0.062) was observed pre-challenge sho-
wing a non-additive effect of enzymes and the yeast
extract in increasing the white blood cell count of
pigs. After 6 h post-challenge, pigs receiving yeast
extract irrespective of enzymes had higher white
blood cell count (P = 0.003) than pigs not receiving
yeast extract, CC pigs had lower white blood cell
count than NCC (P = 0.0004). The LPS-challenged
pigs receiving AGP tended to have higher white blood
Table 2 Primers used for qPCR analysis of immune cytokines
Genea GenBank reference no. Amplicon size, bp Tm
b, °C Primer sequence (5′→3′)
IFN-γ NM_213948.1 231 60 F: GGCCATTCAAAGGAGCATGG
R: GCTCTCTGGCCTTGGAACAT
IL-1β NM_214055.1 131 60 F: GCCCATCATCCTTGAAACGTG
R: GGAGAGCCTTCAGCATGTGT
IL-6 NM_214399.1 149 60 F: TAAGGGAAATGTCGAGGCCG
R: TCCACTCGTTCTGTGACTGC
IL-10 NM_214041.1 179 60 F: TCCGACTCAACGAAGAAGGC
R: AACTCTTCACTGGGCCGAAG
TNF-α NM_214022.1 120 60 F: ATTCAGGGATGTGTGGCCTG
R: CCAGATGTCCCAGGTTGCAT
β-actin XM_005670976.1 179 60 F: CGAGGCTCAGAGCAAGAGAG
R: GGTTGGCCTTAGGGTTCAGG
aIFN-γ interferon gamma, TNF-α tumor necrosis factor-α, IL interleukin
bAnnealing temperature
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Table 3 Effect of supplementing AGP, feed enzymes (ENZ) or yeast extract (YE) without or with ENZ on growth performance of weaned piglets challenged with E. coli LPS
LPS treatmentsc Factoriald Contrast
Itema NCCb AGP CC YE ENZ YE + ENZ SEM Main effect YE Main effect ENZ YE × ENZ NCC vs CC AGP vs CC AGP vs YE AGP vs ENZ AGP vs YE + ENZ
d 1 BW, kg 6.89 6.88 6.90 6.89 6.91 6.86 0.237 NS NS NS NS NS NS NS NS
d 1 to 7
ADG, g/d 159 212 150 140 196 164 31.7 NS NS NS NS NS NS NS NS
ADFI, g/d 191 225 168 160 214 172 24 NS NS NS NS NS 0.06 NS NS
G:F, g/g 0.82 0.93 0.77 0.83 0.91 0.87 0.062 NS NS NS NS NS NS NS NS
d 7 to 11
ADG, g/d 323 226 130 174 170 160 33.2 NS NS NS 0.001 0.07 NS NS NS
ADFI, g/d 366 288 214 229 264 249 29.8 NS NS NS 0.003 NS NS NS NS
G:F, g/g 0.88 0.8 0.59 0.75 0.64 0.66 0.1 NS NS NS 0.07 NS NS NS NS
d 1 to 11
BW, kg 9.3 9.27 8.07 8.39 8.9 8.78 0.319 NS 0.048 NS 0.02 0.02 0.04 NS NS
ADG, g/d 241 239 112 162 192 190 27.3 NS 0.017 NS 0.004 0.004 0.03 NS NS
ADFI, g/d 280 273 177 204 250 210 26.3 NS NS NS 0.02 0.03 0.06 NS 0.08
G:F, g/g 0.85 0.88 0.63 0.79 0.77 0.76 0.061 NS NS NS 0.02 0.01 NS NS NS
aBW body weight, ADG average daily gain, ADFI average daily feed intake, G:F gain to feed ratio
bNCC non-challenged control pigs that were fed the basal diet and injected with sterile saline on d 7
cPigs fed the basal diet without any additive (CC challenged control) or with AGP, YE, ENZ or ENZ + YE and injected with E. coli LPS on d 7















Table 4 Effect of supplementing AGP, feed enzymes (ENZ) or yeast extract (YE) without or with ENZ on PUN (mmol/L) and count of white blood cells (WBC, 109/L), red blood
cells (RBC, 1012/L) and platelets (109/L) of weaned piglets challenged with E. coli LPS
LPS treatmentsb Factorialc Contrast
Item NCCa AGP CC YE ENZ YE + ENZ SEM Main effect YE Main effect ENZ YE × ENZ NCC vs CC AGP vs CC AGP vs YE AGP vs ENZ AGP vs YE + ENZ
PUN
Pre-challenge 2.34 2.28 2.95 2.08 2.52 2.57 0.412 NS NS NS NS NS NS NS NS
6 h post-challenge 2.12 2.58 4.18 2.5 3.42 2.6 0.478 0.03 NS NS 0.01 0.02 NS NS NS
48 h post-challenge 2.16 1.93 2.97 1.24 1.6 1.83 0.285 0.01 NS 0.001 0.08 0.02 0.07 NS NS
96 h post-challenge 1.66 1.78 3.2 2.1 2.55 2.77 0.384 NS NS 0.057 0.01 0.02 NS NS 0.09
WBC
Pre-challenge 16.9 18 17.8 15 14.1 19.3 2.21 NS NS 0.062 NS NS NS NS NS
6 h post-challenge 19.7 10.2 6.5 12.2 7.6 15.5 1.98 0.003 NS NS 0.0004 NS NS 0.07 0.07
48 h post-challenge 18.2 16.8 17.3 17.5 16.2 19.7 1.68 NS NS NS NS NS NS NS NS
96 h post-challenge 19.6 16.7 16.9 16.3 14.5 18.2 1.3 NS NS NS NS NS NS NS NS
RBC
Pre-challenge 5.96 5.54 6.04 6.09 6.04 6.06 0.228 NS NS NS NS NS NS NS NS
6 h post-challenge 5.91 5.68 6.01 6.62 6.33 5.97 0.255 NS NS 0.090 NS NS 0.01 NS NS
48 h post-challenge 5.59 4.96 5.39 5.41 5.48 5.25 0.184 NS NS NS NS NS 0.07 NS NS
96 h post-challenge 5.95 5.18 5.32 5.6 5.46 5.22 0.19 NS NS NS 0.02 NS NS NS NS
Platelet
Pre-challenge 429 534 450 483 447 415 44.8 NS NS NS NS NS NS NS NS
6 h post-challenge 413 309 196 350 205 278 37.3 0.001 NS NS 0.0002 0.04 NS NS NS
48 h post-challenge 445 345 350 338 322 345 29.9 NS NS NS 0.05 NS NS NS NS
96 h post-challenge 449 446 386 520 427 507 61.3 0.06 NS NS NS NS NS NS NS
aNCC non-challenged control pigs that were fed the basal diet and injected with sterile saline on d 7
bPigs fed the basal diet without any additive (CC challenged control) or with AGP, YE, ENZ or ENZ + YE and injected with E. coli LPS on d 7















cell count than those receiving enzymes (P = 0.07)
and lower white blood cell count than those receiving
enzymes + yeast extract (P = 0.07). After 48 and 96 h
post-challenge, treatments had no effect on white
blood cell count.
No effect of dietary treatment was observed for red
blood cells count before LPS challenge. After 6 h
post-challenge, LPS-challenged pigs receiving AGP
had lower red blood cell count (P = 0.01) than chal-
lenged pigs receiving the yeast extract and a tendency
towards an enzymes × yeast extract interaction (P =
0.090) was observed showing a non-additive effect of
enzymes and the yeast extract in decreasing the red
blood cell count of pigs. After 48 h post-challenge,
LPS-challenged pigs receiving AGP tended to have
higher (P = 0.07) red blood cell count than challenged
pigs receiving the yeast extract, whereas after 96 h
post-challenge, compared to NCC pigs, red blood cell
count was lower in CC pigs (P = 0.02).
No effect of dietary treatment was observed for plate-
let count pre-challenge. After 6 h post-challenge, pigs re-
ceiving yeast extract irrespective of enzymes had higher
platelet count (P = 0.001) than pigs not receiving yeast
extract. The platelet count of CC pigs was lower than of
NCC pigs (P = 0.0002) and LPS-challenged pigs receiving
AGP. After 48 h post-challenge, pigs receiving yeast ex-
tract irrespective of enzymes tended to have a higher
platelet count (P = 0.06) than pigs not receiving yeast ex-
tract. The platelet count of CC pigs was lower (P = 0.05)
than of NCC pigs and was not influenced by treatments
after 96 h post-challenge.
Duodenum, jejunum and ileum histomorphology
After 96 h post-challenge, pigs receiving yeast extract ir-
respective of enzymes tended to have a higher duodenal
villus height (P = 0.098) than pigs not receiving yeast ex-
tract. Pigs receiving enzymes irrespective of the yeast ex-
tract had higher duodenal villus height (P = 0.004) than
pigs not receiving enzymes, whereas the duodenal villus
height for CC pigs was lower than that of NCC (P =
0.002) and LPS-challenged pigs receiving AGP (P = 0.03;
Table 5). The duodenal crypt depth for CC pigs was
lower than that of NCC pigs (P = 0.02). Pigs receiving
yeast extract irrespective of enzymes had higher jejunal
villus height (P = 0.049) and jejunal VH:CD (P = 0.03)
than pigs not receiving yeast extract, whereas pigs re-
ceiving enzymes irrespective of the yeast extract had
higher jejunal villus height (P = 0.047) and tended to
have higher jejunal VH:CD (P = 0.07) than pigs not re-
ceiving enzymes. In addition, CC pigs had shorter jejunal
villus height than NCC pigs (P < 0.0001) and LPS-
challenged pigs receiving AGP (P = 0.01). Moreover,
compared with CC pigs, the jejunal VH:CD ratio was
higher in NCC (P = 0.0003) pigs and LPS-challenged pigs
receiving AGP (P = 0.01). The ileal villus height of CC
pigs was shorter than of NCC pigs (P = 0.04) and tended
to be shorter than that of LPS challenged pigs receiving
AGP (P = 0.07).
Rectal temperature, serum and ileum cytokines
Before LPS challenge, pigs receiving enzymes irrespect-
ive of the yeast extract tended to have higher rectal
temperature (P = 0.06) than pigs not receiving enzymes,
whereas no effect of treatments was observed for con-
centration of serum TNF-α and IL-10 (Table 6). After
6 h post-challenge, rectal temperature was higher in CC
pigs (P = 0.003) compared with NCC pigs. In addition,
pigs receiving yeast extract irrespective of enzymes had a
lower concentration of serum TNF-α (P = 0.001) and
higher concentration of serum IL-10 (P = 0.004) than
pigs not receiving yeast extract. Compared with CC pigs,
the concentration of serum TNF-α was lower in NCC
pigs (P < 0.0001) and LPS-challenged pigs receiving AGP
(P = 0.07), whereas the serum IL-10 concentration was
lower in NCC pigs (P = 0.001) but higher in LPS-
challenged pigs receiving AGP (P = 0.02).
After 96 h post-challenge, pigs receiving yeast extract
irrespective of enzymes had a lower expression of IFN-γ
(P > 0.0001), TNF-α (P = 0.013), IL-1β (P = 0.025) and IL-
10 (P = 0.033) than pigs not receiving yeast extract. On
the other hand, pigs receiving enzymes irrespective of
the yeast extract had a lower expression of IL-1β (P =
0.001) and IL-10 (P = 0.019), and a tendency towards
lower expression of TNF-α (P = 0.099) than pigs not re-
ceiving enzymes. Compared to NCC pigs, the CC pigs
had higher expression of ileal IFN-γ (P = 0.04). An en-
zymes × yeast extract interaction (P < 0.0001) was ob-
served showing an additive effect of enzymes and the
yeast extract in downregulating the expression of ileal
IFN-γ in LPS-challenged pigs. Compared with pigs re-
ceiving AGP, the ileal IFN-γ expression was higher (P =
0.008) in LPS-challenged pigs receiving enzymes but
lower (P < 0.0001) in pigs receiving enzymes + yeast
extract.
After 96 h post-challenge, the CC pigs had a higher
expression of ileal TNF-α (P = 0.0003) than NCC pigs. A
tendency towards an enzymes × yeast extract interaction
(P = 0.073) was observed showing a non-additive effect
of enzymes and the yeast extract in downregulating the
expression of ileal TNF-α in LPS-challenged pigs. Com-
pared with LPS challenged pigs receiving AGP, TNF-α
expression was lower in LPS-challenged pigs receiving
yeast extract (P = 0.002), enzymes (P = 0.013) or en-
zymes + yeast extract (P = 0.003).
After 96 h post-challenge, compared with CC pigs,
the expression of ileal IL-1β was lower in NCC pigs
(P = 0.01) and in LPS-challenged pigs receiving AGP
(P = 0.004). The CC pigs tended to have a higher
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Table 5 Effect of supplementing AGP, feed enzymes (ENZ) or yeast extract (YE) without or with ENZ on ileum, jejunum and duodenum histomorphology of weaned piglets
after 96 h of challenge with E. coli LPS
LPS treatmentsc Factoriald Contrast
Itema NCCb AGP CC YE ENZ YE + ENZ SEM Main effect YE Main effect ENZ YE × ENZ NCC vs CC AGP vs CC AGP vs YE AGP vs ENZ AGP vs YE + ENZ
Duodenum, μm
Villus height 532 493 410 480 520 538 24.7 0.098 0.004 NS 0.002 0.03 NS NS NS
Crypt depth 322 308 277 305 314 316 13.1 NS NS NS 0.02 NS NS NS NS
VH:CD 1.65 1.61 1.50 1.58 1.68 1.70 0.088 NS NS NS NS NS NS NS NS
Jejunum, μm
Villus height 465 400 293 385 385 412 26.3 0.049 0.047 NS <.0001 0.01 NS NS NS
Crypt depth 277 269 255 275 282 273 13.2 NS NS NS NS NS NS NS NS
VH:CD 1.70 1.50 1.15 1.40 1.37 1.51 0.092 0.03 0.07 NS 0.0003 0.01 NS NS NS
Ileum, μm
Villus height 329 323 272 294 308 306 18.8 NS NS NS 0.04 0.07 NS NS NS
Crypt depth 265 259 244 233 268 249 13.6 NS NS NS NS NS NS NS NS
VH:CD 1.24 1.26 1.11 1.26 1.17 1.23 0.067 NS NS NS NS NS NS NS NS
aVH:CD villus height/crypt depth; means are averages of at least 15 well oriented villus and crypt columns
bNCC non-challenged control pigs that were fed the basal diet and injected with sterile saline on d 7
cPigs fed the basal diet without any additive (CC challenged control) or with AGP, YE, ENZ or ENZ + YE and injected with E. coli LPS on d 7















Table 6 Effect of supplementing AGP, feed enzymes (ENZ) and yeast extract (YE) without or with ENZ on the rectal temperature (°C), concentration of serum (pg/mL) cytokines
and fold changes (log2) of ileal immune cytokines of weaned piglets challenged with E. coli LPS
LPS treatmentsb Factorialc Contrast
Item NCCa AGP CC YE ENZ YE + ENZ SEM Main effect YE Main effect ENZ YE × ENZ NCC vs CC AGP vs CC AGP vs YE AGP vs ENZ AGP vs YE + ENZ
Rectal temperature
Pre-challenge 38.9 39.2 39.1 39.0 39.2 39.2 0.13 NS 0.06 NS NS NS NS NS NS
6 h post-challenge 39.2 39.9 39.9 39.8 40.1 40.1 0.15 NS NS NS 0.003 NS NS NS NS
Serum TNF-α
Pre-challenge 98 88 96 77 102 93 9.3 NS NS NS NS NS NS NS NS
6 h post-challenge 111 1032 1369 854 1621 933 120.8 0.001 NS NS <.0001 0.07 0.85 0.003 NS
Serum IL-10
Pre-challenge 18 16 29 22 36 27 15.1 NS NS NS NS NS NS NS NS
6 h post-challenge 16 157 99 153 86 156 15.3 0.004 NS NS 0.001 0.02 NS NS NS
Ileum cytokines, 96 h post-challenge
IFN-γ 1.00 1.54 1.46 1.51 2.15 0.54 0.152 <.0001 NS <.0001 0.04 NS NS 0.008 <.0001
TNF-α 1.00 2.52 2.40 1.37 1.60 1.41 0.244 0.013 0.099 0.073 0.0003 NS 0.002 0.013 0.003
IL-1β 1.00 0.95 1.63 1.02 0.77 0.58 0.154 0.025 0.001 NS 0.01 0.004 NS NS NS
IL-6 1.00 0.86 0.85 0.83 0.69 1.12 0.130 NS NS NS NS NS NS NS NS
IL-10 1.00 0.60 1.31 0.74 0.71 0.76 0.123 0.033 0.019 0.012 0.09 0.0003 NS NS NS
aNCC non-challenged control pigs that were fed the basal diet and injected with sterile saline on d 7
bPigs fed the basal diet without any additive (CC challenged control) or with AGP, YE, ENZ or ENZ + YE and injected with E. coli LPS on d 7















expression of ileal IL-10 (P = 0.09) than NCC pigs. An
enzymes × yeast extract interaction (P = 0.012) was ob-
served showing a non-additive effect of enzymes and
the yeast extract in downregulating the expression of
ileal IL-10 in LPS-challenged pigs. Compared with CC
pigs, IL-10 expression was lower in LPS-challenged
pigs receiving AGP (P = 0.0003).
Discussion
The AGP, yeast extract and enzymes supplements did not
affect performance during the first 7 d of weaning. Sauer
et al. [20] and Andrés-Elias et al. [21] supplemented 0.1
and 0.15 % yeast extract in piglet starter diets, res-
pectively, and reported no effect of yeast extract on growth
performance. Between d 7 and 11 (post-challenge), the LPS
challenge reduced ADG, ADFI and G:F of CC pigs. This
observation is consistent with the findings of Liu et al. [22]
and Liu et al. [23] showing that LPS challenge negatively
impacts growth performance in pigs. Although none of the
supplements was able to fully protect the pigs from weight
loss or to increase their feed intake between d 7 and 11, the
LPS impact on ADG tended to be reduced in AGP receiv-
ing pigs compared with other LPS-challenged treatments.
This beneficial effect of AGP on growth performance was
further seen in the overall experimental period (d 1 to 11)
with AGP pigs having better ADG, ADFI and GF than CC
pigs, and tended to have better G:F than pigs supplemented
with yeast extract. These observations suggest that AGP
supplemented pigs had better recovery of weight and feed
intake after LPS challenge than those supplemented with
yeast extract. Weber et al. [24] and Skinner et al. [25] re-
ported that AGP improves ADG during the nursery phase,
whereas Wu et al. [26] reported that piglets receiving in-
feed AGP and challenged with enterotoxigenic E. coli had
higher ADG and G:F than control. Niewold [27] suggested
that AGP improve gut health and growth performance of
livestock by reducing the gut pathogen load and competi-
tion for nutrients between the host and gut microbes. This
effect may also be associated with the immunoregulatory
role of AGP [28]. Although enzymes supplementation
tended to improve ADG (d 1 to 11), there was no synergis-
tic effect between yeast extract and enzymes on ADG.
The reduced white blood cell and platelet counts in
CC pigs is due to LPS induced autoimmunity and suggests
an increased incidence or severity of infection [29, 30].
Platelets play a crucial role in blood clotting and as the
first responders to sites of vascular injury or pathogen in-
vasion, platelets play multiple roles in the modulation of
both innate and adaptive immunity thereby boosting host
defense against infection [30]. The observation that LPS-
challenged pigs receiving yeast extract maintained higher
white blood cell and platelet count than CC pigs and
higher red blood cell count than LPS-challenged pigs
receiving AGP at 6 h post-challenge suggests that yeast
extract supplementation either had a role in preventing
blood cells death or sustained moderate blood cell forma-
tion during the challenge period.
A 100 μg/kg dosage of E. coli LPS has been shown to
induce gut injury in pigs [23, 31]. In the present study,
gut injury was observed in piglets that received 60 μg/kg
of E. coli LPS. Supplementing yeast extract to pigs without
or with enzymes reduced villus atrophy in the jejunum
and duodenum, and the villus height/crypt depth ratio in
the jejunum when compared with the non-challenged
control pigs, and the effect was similar to that of AGP
supplementation. The increase in villus height and villus/
crypt ratio indicates an improvement in the digestion and
absorption of nutrients [31, 32]. Enterocytes have limited
capacity for de novo nucleotides synthesis [33, 34] and
thus the increased pool of dietary nucleotides by yeast
extract supplementation promoted intestinal tissue growth
and development. In addition, pathogens with mannose-
specific type-1 fimbriae, such as E. coli and Salmonella,
bind with the α-mannans instead of attaching to intestinal
epithelial cells, which may reduce inflammation that leads
to intestinal villi atrophy [35].
Injection of LPS induces fever in pigs by stimulating
the production of cytokines such as IL-1, TNF-α and
IFN-γ, which are regarded as endogenous mediators of
fever [36]. In this study, 6 h post-challenge CC pigs
showed a significant rise in body temperature compared
to NCC pigs as also observed by Pi et al. [37] and none
of the supplements protected the pigs from fever devel-
opment. The concentration of serum TNF-α and IL-10
were measured as indicators of systemic pro- and anti-
inflammation responses, respectively. Pigs receiving AGP
or yeast extract without or with enzymes had less concen-
tration of serum TNF-α and higher concentration of IL-10
than CC pigs, hence, implying that AGP and enzymes +
yeast extract supplementation lowered pro-inflammation
of the immune system. The ileum immune response was
also influenced by both LPS and the supplements. The ob-
served upregulation of ileal TNF-α and IL-1β 96 h post-
challenge in the CC pigs compared to NCC pigs suggests
development of inflammation in CC pigs, which if pro-
longed leads to tissue damage such as the observed villus
atrophy in these pigs [38]. In contrast, pigs in the yeast
extract supplemented treatments had downregulated
levels of expression of these pro-inflammatory cytokines
thus suggesting that the yeast extract induced beneficial
immunoregulatory responses post-challenge that was evi-
denced by lower expression of TNF-α and IL-1β, and con-
sequently that of IL-10 compared to the LPS-challenged
control group. The overproduction of proinflammatory
cytokines is associated with anorexia development, and
may explain the observed reduction in ADFI in LPS-
challenged pigs in this study [39, 40].
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In the present study, LPS-challenged control pigs had
higher PUN than non-challenged control pigs. This is
consistent with the study of Webel et al. [41] reporting
that LPS challenge increases the PUN level in piglets
due to muscle proteolysis as a result of increased inflam-
mation. Owusu-Asiedu et al. [42] suggested that the re-
leased amino acids due to inflammation may be channeled
to the liver to synthesize acute phase proteins and/or to
serve as an energy source. Supplementing yeast extract
without or with enzymes had similar effects as AGP in re-
ducing PUN level compared with the LPS-challenged con-
trol. The reduction in PUN level is an indicator of reduced
muscle protein breakdown [41] and is consistent with the
observed reduced production of proinflammatory cyto-
kines in the yeast extract and AGP receiving pigs. These
observations suggest that supplementing yeast extract or
AGP was beneficial to piglets and reduced the severity of
the LPS challenge. Such a response may promote efficiency
in utilization of dietary amino acids for proteinaceous
tissue growth [39].
Taken together, after the immune system stimulation
using E. coli LPS, the growth performance, platelets
count, villus height of the jejunum and duodenum, and
immune status of LPS-challenged control pigs was
negatively affected compared with the non-challenged
control. Compared to LPS-challenged control, supple-
menting yeast extract + enzymes lowered and increased
the expression of ileal IFN-γ and IL-10, respectively,
and improved histomorphological measurements but
did not affect growth performance. Most of the ob-
served enzymes × yeast extract interactions or tenden-
cies towards interaction were non-additive except that
of lowering ileal IFN-γ. The most pronounced benefi-
cial effects of yeast extract supplementation were on lowe-
ring PUN, villus atrophy, and levels of pro-inflammatory
cytokines, and maintaining blood cell counts close to that
of non-challenged control pigs.
The immunomodulating effect of the yeast extract is
multifaceted and may be associated with the nucleo-
tides and cell wall polysaccharides present in the yeast
extract. In response to the inflammatory challenge, the
nucleotides sourced from the yeast extract can be chan-
neled to influence the development and maturation of
important tissues of the immune system and the intes-
tinal mucosa. This supports the suggestion by Gaskins
et al. [43] that the weaned pig first invests substantially
in defensive efforts to sequester gut microbes away
from the epithelial surface, and second to quickly
mount immune responses against microbes that breach
epithelial defenses. This re-direction of nutrients from
growth towards fortification of the immune system and
maturation of gut structures may explain why beneficial
responses on growth performance may not be observed
within a short term of supplementing the yeast extract
nucleotides. However, a faster maturation of the gut
and immune system tissues, may in the long-run
support faster growth of the pig, hence the effect of nu-
cleotides may be long-lasting. On the other hand, there
is evidence that yeast β-glucans are associated with
downregulation and upregulation of the expression of
pro-inflammatory and anti-inflammatory cytokines, res-
pectively, when piglets immune system is challenged
with LPS [9] or E. coli [10], and that yeast-derived α-
mannans has been associated with improved enhanced
function of macrophages in the intestinal lamina pro-
pria [11]. The yeast cell wall polysaccharides may also
provide binding sites for pathogens hence mediating
their elimination from the gut [44].
Conclusions
In conclusion, LPS-challenged piglets fed diets supple-
mented with yeast extract without or with enzymes
expressed similar beneficial responses as those fed diets
with AGP in terms of lowering PUN concentration,
reducing duodenal and ileal villi atrophy, and downregu-
lating serum and ileal proinflammatory cytokines. This
suggests that supplementation of the yeast extract was
associated with promotion of the health of piglets during
the immediate post-weaning period.
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